You have 7 free searches left this month | for more free features.

Santen

Showing 26 - 50 of 147

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tear, Dry Eye Syndromes Trial in Seoul (3% diquafosol eyedrops, Silicone punctal plug insertion)

Completed
  • Tear
  • Dry Eye Syndromes
  • 3% diquafosol eyedrops
  • Silicone punctal plug insertion
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University College of Medicine
Jul 7, 2022

Depressive Symptoms, Aging, Loneliness Trial (Yetitablet gaming)

Not yet recruiting
  • Depressive Symptoms
  • +5 more
  • Yetitablet gaming
  • (no location specified)
Aug 30, 2023

Non Infectious Uveitis Trial in Worldwide (DE-109 Intravitreal Injections, Sham Procedure)

Recruiting
  • Non Infectious Uveitis
  • DE-109 Intravitreal Injections
  • Sham Procedure
  • Phoenix, Arizona
  • +71 more
Nov 4, 2021

Primary Open Angle Glaucoma, Ocular Hypertension Trial in United States (DE-126 Ophthalmic Solution 0.002% QD, Timolol Maleate

Completed
  • Primary Open Angle Glaucoma
  • Ocular Hypertension
  • DE-126 Ophthalmic Solution 0.002% QD
  • Timolol Maleate Ophthalmic Solution 0.5% BID
  • Chandler, Arizona
  • +40 more
Feb 10, 2022

Normal Tension Glaucoma, Primary Open-angle Glaucoma, Glaucoma, Suspect Trial in Seongnam-si, Seoul (Eybelis ophthalmic solution

Recruiting
  • Normal Tension Glaucoma
  • +3 more
  • Eybelis ophthalmic solution 0.002%
  • Seongnam-si, Korea, Republic of
  • +7 more
Mar 6, 2022

Conjunctivitis, Vernal Trial in Paris (Cyclosporine NOVA22007 0.05%, Cyclosporine NOVA22007 0.1%, Vehicle)

Completed
  • Conjunctivitis, Vernal
  • Cyclosporine NOVA22007 0.05%
  • +2 more
  • Paris, France
    Groupe Hospitalier Bichat-Claude Bernard
Nov 12, 2021

Diabetic Macular Edema Trial in Singapore (Aflibercept Injection [Eylea])

Unknown status
  • Diabetic Macular Edema
  • Aflibercept Injection [Eylea]
  • Singapore, Singapore
    Singapore National Eye Centre
Apr 18, 2019

Age-Related Macular Degeneration Trial in Philippines, United States (2.0 mg DE-122 Injectable Solution + Lucentis, 4.0 mg

Completed
  • Age-Related Macular Degeneration
  • 2.0 mg DE-122 Injectable Solution + Lucentis
  • +2 more
  • Gilbert, Arizona
  • +13 more
Jun 22, 2021

Dry Eye, Meibomian Gland Dysfunction Trial in Guangzhou (Warm compresses, 3% Diquafosol Sodium Eye Drops)

Not yet recruiting
  • Dry Eye
  • Meibomian Gland Dysfunction
  • Warm compresses
  • 3% Diquafosol Sodium Eye Drops
  • Guangzhou, Guangdong, China
    Zhongshan Ophthalmic Center, Sun Yat-Sen University
Aug 5, 2022

Students Trial in New Taipei City (Empathy experience courses and case-base clinical reasoning, case studies)

Not yet recruiting
  • Students
  • Empathy experience courses and case-base clinical reasoning
  • case studies
  • New Taipei City, Taiwan
    Taipei Medical University Shuang Ho Hospital
Jul 28, 2022

Climacteric Syndrome, Menopause, Hypoestrogenism Trial in Santos (s.c 25 mg estradiol pellet)

Recruiting
  • Climacteric Syndrome
  • +2 more
  • s.c 25 mg estradiol pellet
  • Santos, São Paulo, Brazil
    Irmandade Da Santa Casa De Misericórdia De Santos - Science Vall
Nov 13, 2023

Vernal Keratoconjunctivitis Trial in Worldwide (NOVA22007 ''Ciclosporin'', Placebo)

Completed
  • Vernal Keratoconjunctivitis
  • NOVA22007 ''Ciclosporin''
  • Placebo
  • Glendale, California
  • +45 more
Mar 2, 2022

Glaucoma, Primary Open Angle Trial in Tainan (Latanoprost, tafluprost)

Completed
  • Glaucoma, Primary Open Angle
  • Tainan, Taiwan
    Chi Mei Hospital Liouying Branch
Feb 3, 2021

Adaptive Expertise, Error Management Training, Learning Trial in Stanford (Error Management Training (Difficult), Error

Enrolling by invitation
  • Adaptive Expertise
  • +2 more
  • Error Management Training (Difficult)
  • +2 more
  • Stanford, California
    Stanford University
Jul 19, 2022

Primary Open-angle Glaucoma and Ocular Hypertension Trial in United States (DE-117 Ophthalmic Solution)

Unknown status
  • Primary Open-angle Glaucoma and Ocular Hypertension
  • DE-117 Ophthalmic Solution
  • Chandler, Arizona
  • +30 more
Jan 7, 2020

Concordance of Molecular Classification Based on Fine Needle

Not yet recruiting
  • Papillary Thyroid Cancer
    • Calgary, Alberta, Canada
      Foothills Medical Centre
    Nov 17, 2023

    Dry Eye Trial in Shanghai (Verum Electroacupuncture, Sham Electroacupuncture)

    Not yet recruiting
    • Dry Eye
    • Verum Electroacupuncture
    • Sham Electroacupuncture
    • Shanghai, Shanghai, China
      Guang Yang
    Sep 21, 2022

    Dry Eye Trial in Shenyang (Intense pulsed light, Diquafosol tetrasodium)

    Not yet recruiting
    • Dry Eye
    • Intense pulsed light
    • Diquafosol tetrasodium
    • Shenyang, Liaoning, China
      He Eye Hospital
    Jan 19, 2023

    Dry Eye, Cataract Surgery Trial in Seoul (1. Use of preservative free diquafosol ophthalmic solution after cataract surgery, 2.

    Completed
    • Dry Eye
    • Cataract Surgery
    • 1. Use of preservative free diquafosol ophthalmic solution after cataract surgery
    • +2 more
    • Seoul, Korea, Republic of
      Department of Ophthalmology, Yonsei Univeristy College of Medici
    Sep 28, 2020

    Dry Eye Disease With Severe Keratitis Trial in Worldwide (Open-label Ikervis, Masked Ikervis, Vehicle Comparator: Masked

    Active, not recruiting
    • Dry Eye Disease With Severe Keratitis
    • Open-label Ikervis
    • +2 more
    • Brno, Jihomoravský, Czechia
    • +44 more
    May 30, 2022

    Open-angle Glaucoma, Ocular Hypertension Trial in Changsha, Shanghai (A preservative-free, a clear, colorless sterile aqueous

    Unknown status
    • Open-angle Glaucoma, Ocular Hypertension
    • A preservative-free, a clear, colorless sterile aqueous ophthalmic solution containing 0.015mg of tafluprost and 5.0mg of timolol in 1mL
    • A preservative-free, a clear, colorless sterile aqueous ophthalmic solution containing 0.015mg of tafluprost in 1mL
    • Changsha, China
    • +1 more
    Jun 16, 2020

    Primary Open-angle Glaucoma and Ocular Hypertension Trial in United States (DE-117 Ophthalmic Solution QD, DE-117 Ophthalmic

    Completed
    • Primary Open-angle Glaucoma and Ocular Hypertension
    • DE-117 Ophthalmic Solution QD
    • DE-117 Ophthalmic Solution BID
    • Los Angeles, California
    • +12 more
    Jul 20, 2020

    Myopia Trial in Singapore (DE-127 Ophthalmic Solution low dose, DE-127 Ophthalmic Solution medium dose, DE-127 Ophthalmic

    Completed
    • Myopia
    • DE-127 Ophthalmic Solution low dose
    • +3 more
    • Singapore, Singapore
      Singapore National Eye Centre
    Aug 25, 2020

    Ocular Surface Disease in Malaysian Glaucoma Patients

    Unknown status
    • Primary Open-angle Glaucoma
    • +4 more
      • (no location specified)
      Oct 25, 2020

      Glaucoma and Ocular Hypertension Trial in United States (DE-117, 0.0015% tafluprost, DE-117 and 0.0015% tafluprost)

      Completed
      • Glaucoma and Ocular Hypertension
      • Newport Beach, California
      • +9 more
      Apr 16, 2018